Tema Oncology ETF (CANC)
Market Open
20 Jul, 13:37
NASDAQ (NMS) NASDAQ (NMS) Primary $
41. 20
+0.3
+0.7211%
$
129.58M Market Cap
0.6% Div Yield
590 Volume
$ 40.91
Previous Close 
Want to track CANC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks
Tema Oncology ETF receives a Hold rating due to inconsistent returns but it does currently have a high Quant Ranking in the healthcare subclass. CANC offers diversified exposure across market caps and geographies, focusing on firms combating cancer through biotech, pharmaceuticals, diagnostics, and devices. The ETF holds 55 stocks, with top 10 comprising 40% of the portfolio, balancing established giants and innovative small-caps.
Seekingalpha | 3 months ago
Disruptive Theme of the Week – Breakthroughs in Medicine
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.
Etftrends | 1 year ago
